Evidence map›Paper›PMID 36917200›Full record

ArticleInflammatory bowel diseases2023

Hospitalization Rates for Inflammatory Bowel Disease Are Decreasing Over Time: A Population-based Cohort Study.

Michael J Buie, Stephanie Coward, Abdel-Aziz Shaheen, Jayna Holroyd-Leduc, Lindsay Hracs, Christopher Ma, Remo Panaccione, Eric I Benchimol, Charles N Bernstein, Alain Bitton and 9 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Inflammatory bowel diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 11 institutions in 1 country.

Michael J BuieDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Stephanie CowardDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0003-0675-7226
Abdel-Aziz ShaheenDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Jayna Holroyd-LeducDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Lindsay HracsDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.
Christopher MaDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0002-4698-9948
Remo PanaccioneDepartment of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Eric I BenchimolSickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada.
Charles N BernsteinDepartment of Medicine, and the University of Manitoba IBD Clinical and Research Centre, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
Alain BittonDivision of Gastroenterology and Hepatology, McGill University and McGill University Health Centre, Montreal, Quebec, Canada.
Anthony R OtleyDepartment of Pediatrics, Faculty of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada.
Jennifer L JonesDivision of Digestive Care & Endoscopy, Department of Medicine, Dalhousie University, Halifax, NS, Canada.ORCID 0000-0002-6380-6728
Sanjay K MurthyDepartment of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
M Ellen KuenzigSickKids Inflammatory Bowel Disease Centre, Division of Gastroenterology, Hepatology and Nutrition, The Hospital for Sick Children, Toronto, Ontario, Canada.
Juan-Nicolás Peña-SánchezDepartment of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Laura E TargownikZane Cohen Centre for Digestive Diseases, Mount Sinai Health, Toronto, Ontario, Canada.
Harminder SinghDepartments of Medicine and Community Health Sciences, University of Manitoba, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.ORCID 0000-0002-9354-2356
Antonio Avina-ZubietaDivision of Rheumatology, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Gilaad G KaplanDepartment of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0003-2719-0556
University of Calgary · CADalhousie University · CACancerCare Manitoba · CAMcGill University Health Centre · CASickKids Foundation · CASinai Health System · CAUniversity of British Columbia · CAUniversity of Manitoba · CAUniversity of Ottawa · CAUniversity of Saskatchewan · CAUniversity of Toronto · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRecent advances in the management of inflammatory bowel disease (IBD) striving for new treatment targets may have decreased rates of hospitalization for flares. We compared all-cause, IBD-related, and non-IBD-related hospitalizations while accounting for the rising prevalence of IBD.

methodsPopulation-based, administrative health care databases identified all individuals living with IBD in Alberta between fiscal year 2002 and 2018. Hospitalization rates (all-cause, IBD-related, and non-IBD-related) were calculated using the prevalent Alberta IBD population. Hospitalizations were stratified by disease type, age, sex, and metropolitan status. Data were age and sex standardized to the 2019 Canadian population. Log-linear models calculated Average Annual Percentage Change (AAPC) in hospitalization rates with associated 95% confidence intervals (CIs).

resultsFrom 2002-2003 to 2018-2019, all-cause hospitalization rates decreased from 36.57 to 16.72 per 100 IBD patients (AAPC, -4.18%; 95% CI, -4.69 to -3.66). Inflammatory bowel disease-related hospitalization rate decreased from 26.44 to 9.24 per 100 IBD patients (AAPC, -5.54%; 95% CI, -6.19 to -4.88). Non-IBD-related hospitalization rate decreased from 10.13 to 7.48 per 100 IBD patients (AAPC, -1.82%; 95% CI, -2.14 to -1.49). Those over 80 years old had the greatest all-cause and non-IBD-related hospitalization rates. Temporal trends showing decreasing hospitalization rates were observed across age, sex, IBD type, and metropolitan status.

conclusionsHospitalization rates are decreasing for all-cause, IBD-related, and non-IBD-related hospitalizations. Over the past 20 years, the care of IBD has transitioned from hospital-based care to ambulatory-centric IBD management.

Indexed as

Colitis, UlcerativeInflammatory Bowel DiseasesAged, 80 and overCanadaCohort StudiesDelivery of Health CareHospitalizationHumansCrohn’s diseaseepidemiologyhospitalization ratesinflammatory bowel diseaseulcerative colitis

Identifiers

PMID36917200
PMCPMC10547231
OpenAlexW4324129686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.